Sepsisul în infecţiile supurativ-necrotice ale ţesuturilor moi
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
1064 7
Ultima descărcare din IBN:
2023-11-29 19:06
SM ISO690:2012
HOTINEANU, Vladimir, BALICA, Ion, BOGDAN, Valeriu, ILIADI, Alexandru, SALAUR, Sergiu, TRINCA, Gheorghe, RUSU, Ovidiu. Sepsisul în infecţiile supurativ-necrotice ale ţesuturilor moi. In: Arta Medica , 2006, nr. 2(17), pp. 3-8. ISSN 1810-1852.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Arta Medica
Numărul 2(17) / 2006 / ISSN 1810-1852 /ISSNe 1810-1879

Sepsisul în infecţiile supurativ-necrotice ale ţesuturilor moi

Pag. 3-8

Hotineanu Vladimir, Balica Ion, Bogdan Valeriu, Iliadi Alexandru, Salaur Sergiu, Trinca Gheorghe, Rusu Ovidiu
 
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
 
Disponibil în IBN: 17 decembrie 2013


Rezumat

Analiza retrospectivă a cazurilor de afecţiuni purulente şi necrotice ale ţesuturilor moi, tratate în Secţia Reanimare Septică a SCR, pe parcursul anilor 1995-2005, a stabilit că la 62,5% dintre pacienţi au evoluat în formă de sepsis sever, conform criteriilor de Consens Internaţional, inclusiv la 20% s-a dezvoltat şoc septic. Caracteristicile clinico-morfologice principale ale acestei variante de sepsis sunt: frecvenţa bacteremiei (preponderent stafilococice), afectarea de natură toxico-metastatică a organelor parenchimatoase (în special a plămînilor), dereglarea gravă a metabolismului cu creşterea indicilor severităţii septice (SIRS, MODS, APACHE II, SAPS II, ILI). Mortalitatea generală în grupul de studiu a fost de 19,5%, pe când la cei cu sepsis sever de 31,25%.

This retrospective analysis of cases of purulent–necrotic soft tissue infections, treated during 1995-2005 in the intensive care department of the Clinical republican Hospital of Moldova established that 62,5% of cases were severe sepsis (including 20% patients with septic shock) according to International Consensus criteria. In this type of sepsis we observed frequent bacteremia (mainly staphylococcal), toxico-metastatic distant parenchimatous injury (especially pulmonary), metabolic disorders with high value of severity scores (SIRS, MODS, APACHE II, SAPS II, ILI). General mortality was 19,5%, but in group with severe sepsis fatality rate was 31,25%.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-10289</cfResPublId>
<cfResPublDate>2006-04-03</cfResPublDate>
<cfVol>17</cfVol>
<cfIssue>2</cfIssue>
<cfStartPage>3</cfStartPage>
<cfISSN>1810-1852</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/10289</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Sepsisul în infecţiile supurativ-necrotice ale ţesuturilor moi</cfTitle>
<cfAbstr cfLangCode='RO' cfTrans='o'>Analiza retrospectivă a cazurilor de afecţiuni purulente şi necrotice ale ţesuturilor moi, tratate în Secţia Reanimare Septică a SCR, pe parcursul anilor 1995-2005, a stabilit că la 62,5% dintre pacienţi au evoluat în formă de sepsis sever, conform criteriilor de Consens Internaţional, inclusiv la 20% s-a dezvoltat şoc septic. Caracteristicile clinico-morfologice principale ale acestei variante de sepsis sunt: frecvenţa bacteremiei (preponderent stafilococice), afectarea de natură toxico-metastatică a organelor parenchimatoase (în special a plămînilor), dereglarea gravă a metabolismului cu creşterea indicilor severităţii septice (SIRS, MODS, APACHE II, SAPS II, ILI). Mortalitatea generală în grupul de studiu a fost de 19,5%, pe când la cei cu sepsis sever de 31,25%.</cfAbstr>
<cfAbstr cfLangCode='EN' cfTrans='o'>This retrospective analysis of cases of purulent–necrotic soft tissue infections, treated during 1995-2005 in the intensive care department of the Clinical republican Hospital of Moldova established that 62,5% of cases were severe sepsis (including 20% patients with septic shock) according to International Consensus criteria. In this type of sepsis we observed frequent bacteremia (mainly staphylococcal), toxico-metastatic distant parenchimatous injury (especially pulmonary), metabolic disorders with high value of severity scores (SIRS, MODS, APACHE II, SAPS II, ILI). General mortality was 19,5%, but in group with severe sepsis fatality rate was 31,25%.</cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-231</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-20780</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-20898</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11189</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-32957</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-32958</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-35561</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-231</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-231-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
<cfFamilyNames>Хотиняну</cfFamilyNames>
<cfFirstNames>Владимир</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-20780</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-20780-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
<cfFamilyNames>Balica</cfFamilyNames>
<cfFirstNames>Ion</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-20898</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-20898-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
<cfFamilyNames>Bogdan</cfFamilyNames>
<cfFirstNames>Valeriu</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11189</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11189-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
<cfFamilyNames>Илиади</cfFamilyNames>
<cfFirstNames>Александру</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-32957</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-32957-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
<cfFamilyNames>Salaur</cfFamilyNames>
<cfFirstNames>Sergiu</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-32958</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-32958-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
<cfFamilyNames>Trinca</cfFamilyNames>
<cfFirstNames>Gheorghe</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-35561</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-35561-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2006-04-03T24:00:00</cfStartDate>
<cfFamilyNames>Rusu</cfFamilyNames>
<cfFirstNames>Ovidiu</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>